CARE CHL Hospitals | Indore, LIG Square - Endocrinology department
Research site
Site insights
Top conditions
Top treatments
Tirzepatide
LY3298176
Saroglitazar
LY3437943
Retatrutide
Parent organization
This site is a part of CARE CHL Hospitals, Indore
Data sourced from clinicaltrials.gov
Contact this site
Madhumati Pahuja
Verified by this site
Active trials
3 of 5 total trials
The purpose of this study is to is to evaluate the efficacy and safety of retatrutide in participants with type 2 diabetes in participants who have o...
Enrolling
Overweight
Obesity
Drug: Placebo
Drug: Retatrutide
The purpose of the trial is to assess the efficacy and safety of tirzepatide to dulaglutide in participants with type 2 diabetes and increased cardio...
Active, not recruiting
Type 2 Diabetes Mellitus
Drug: Tirzepatide
Drug: Dulaglutide
A Phase 4, non-randomized, multicentre, open-label, single-arm study to evaluate the safety and efficacy of Saroglitazar 4 mg in patients with non-al...
Enrolling
Dyslipidemias
Obesity
Drug: Saroglitazar
Trial sponsors
X
Z
Clinical trials
Research sites
Resources
Legal
© Copyright 2024 Veeva Systems